Skip to main content
XPOF
NYSE Trade & Services

Xponential Fitness Reports Weak Q4 & FY25 Results, Issues Bleak 2026 Outlook, Settles $40M in Legal Claims

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
9
Price
$6.5
Mkt Cap
$392.494M
52W Low
$5.38
52W High
$13.99
Market data snapshot near publication time

summarizeSummary

Xponential Fitness reported significant declines in Q4 and full-year 2025 financial performance, including negative same-store sales and adjusted EBITDA, and provided a weak 2026 outlook with projected revenue and profit decreases, alongside finalizing nearly $40 million in legal and regulatory settlements.


check_boxKey Events

  • Weak Q4 and Full Year 2025 Financial Results

    For Q4 2025, North America same store sales decreased by 4% (compared to 7% growth in Q4 2024), and Adjusted EBITDA declined 26% to $22.9 million. For the full year 2025, Adjusted EBITDA decreased 4% to $111.8 million, and the company swung to an adjusted net loss of $18.4 million from an adjusted net income of $1.8 million in 2024.

  • Deteriorating 2026 Outlook

    The company initiated a full year 2026 outlook projecting a 16% decrease in revenue (midpoint) to $260.0-$270.0 million, a 6% decrease in Adjusted EBITDA (midpoint) to $100.0-$110.0 million, and a 20% decrease in net new studio openings (midpoint) to 150-170. North America system-wide sales are projected to increase by only 1% at the midpoint.

  • Significant Legal and Regulatory Settlements

    Xponential Fitness finalized a $17.0 million settlement with the FTC (payable over 12 months) and a $22.75 million settlement with over 500 current and former franchisees (payable over 35 months). These combined payments of $39.75 million aim to substantially reduce regulatory and legal uncertainty.


auto_awesomeAnalysis

Xponential Fitness faces substantial headwinds as evidenced by its latest financial results and forward guidance. The significant deceleration in same-store sales, coupled with a sharp decline in adjusted EBITDA and a swing to a considerable adjusted net loss, indicates deteriorating operational performance. The 2026 outlook further compounds these concerns, projecting continued revenue and profit contraction, and a slowdown in studio expansion. While the $39.75 million in legal and regulatory settlements resolve significant uncertainties, the material financial cost represents a substantial burden for the company. Investors should closely monitor the company's ability to reverse these negative trends and manage its debt load amidst a challenging operating environment.

At the time of this filing, XPOF was trading at $6.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $392.5M. The 52-week trading range was $5.38 to $13.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed XPOF - Latest Insights

XPOF
Apr 06, 2026, 8:22 PM EDT
Filing Type: 8-K
Importance Score:
9
XPOF
Apr 06, 2026, 8:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
XPOF
Apr 01, 2026, 1:14 PM EDT
Source: Reuters
Importance Score:
8
XPOF
Mar 10, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
8
XPOF
Mar 04, 2026, 8:16 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
9
XPOF
Mar 04, 2026, 3:04 PM EST
Source: Wiseek News
Importance Score:
8
XPOF
Mar 03, 2026, 9:50 PM EST
Filing Type: 10-K
Importance Score:
9
XPOF
Feb 27, 2026, 3:03 PM EST
Source: Unknown
Importance Score:
9
XPOF
Feb 26, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
9